Results overview: Found 2 records in 0.03 seconds.
Articles, 1 records found
Research literature, 1 records found
Articles 1 records found  
1.
30 p, 2.0 MB The Present and Future of Prostate Cancer Urine Biomarkers / Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Llauradó, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Planas, Jacques (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Cooper, Colin (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ; Reventós, Jaume (Department of Basic Sciences, International University of Catalonia, 08017 Barcelona, Spain) ; Clark, Jeremy (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ; Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca)
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. [...]
2013 - 10.3390/ijms140612620
International journal of molecular sciences, Vol. 14 (june 2013) , p. 12620-12649  

Research literature 1 records found  
1.
174 p, 6.1 MB Micro-RNAs in ovarian cancer as tools for diagnosis and therapy / Majem Cavaller, Blanca ; Santamaria Margalef, Anna, dir. ; Rigau Resina, Marina, dir. ; Llauradó i Miravall, Marta, dir. (Hospital Universitari Vall d'Hebron) ; Miró, Rosa, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
El càncer d'ovari (CO) és la cinquena causa del càncer en dones i la principal causa de mort entre les malalties ginecològiques. Els símptomes inespecífics i les eines diagnòstiques actualment insuficients no detecten la malaltia en estadis inicials, quan la supervivència és del 90%. [...]
Ovarian cancer (OC) is the fifth cause of cancer in women and the leading cause of death among gynecological malignancies in developed countries. The unspecific symptoms and currently insufficient diagnostic tools fail to detect the disease at an early stage, when the 5-years survival is 90%. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.